- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
UPDATED Apr 04, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
54 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIOA B | kr210.40 | -2.3% | -15.2% | kr18.6b | kr366.20 | PE81.1x | E48.2% | 0% | ||
NEU | AU$20.77 | -2.1% | 59.6% | AU$2.6b | AU$26.74 | PE16.9x | E5.2% | n/a | ||
300406 | CN¥19.30 | -2.6% | -8.2% | CN¥11.3b | n/a | PE21.6x | E22.0% | 0.5% | ||
2675 | CN¥13.66 | 0% | -18.5% | CN¥11.3b | CN¥20.30 | PE42.9x | E30.2% | 1.1% | ||
BONEX | kr231.60 | 1.6% | 169.8% | kr15.1b | kr273.67 | PE61.5x | E14.0% | n/a | ||
6600 | HK$17.96 | 12.0% | 69.4% | HK$10.9b | HK$17.86 | PE9x | E4.7% | 0% | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | ||
PCRX | US$28.16 | -3.6% | -32.8% | US$1.3b | US$45.73 | PE31.2x | E29.3% | n/a | ||
2275 | CN¥14.35 | 0.8% | -20.3% | CN¥8.4b | n/a | PE21.6x | E26.4% | 4.2% | ||
MDXG | US$7.00 | -9.1% | 110.8% | US$1.0b | US$12.44 | PE18.4x | E15.0% | n/a | ||
2877 | HK$9.90 | 1.7% | 17.3% | HK$7.5b | HK$14.09 | PE7.1x | E14.5% | 4.6% | ||
2160 | JP¥2,878.00 | -7.5% | 178.1% | JP¥143.5b | JP¥4,100.00 | PE17.7x | E24.9% | n/a | ||
603439 | CN¥15.52 | -3.2% | -10.0% | CN¥6.4b | CN¥19.84 | PE24.9x | E23.2% | 0.6% | ||
MARKSANS | ₹161.00 | 6.0% | 122.5% | ₹73.0b | n/a | PE23.1x | E20.6% | 0.3% | ||
A214450 | ₩113,600.00 | 12.6% | 30.9% | ₩1.2t | ₩175,000.00 | PE15.1x | E20.5% | 0.8% | ||
603229 | CN¥10.44 | 2.8% | -35.4% | CN¥6.2b | n/a | PE21.8x | E27.3% | 0.8% | ||
A214370 | ₩21,550.00 | -5.5% | -49.2% | ₩1.1t | ₩50,000.00 | PE26.5x | E42.7% | 3.0% | ||
688566 | CN¥24.83 | 1.7% | -16.3% | CN¥4.7b | n/a | PE21.7x | E21.3% | 0% | ||
1681 | HK$5.55 | -0.9% | 17.3% | HK$4.4b | HK$7.10 | PE5.2x | E12.5% | 10.8% | ||
524348 | ₹493.05 | 13.6% | 27.1% | ₹45.3b | ₹562.00 | PE25.2x | E28.2% | 0.2% | ||
BXPHARMA | ৳117.10 | 2.2% | -19.9% | ৳52.2b | ৳153.50 | PE10.6x | E15.0% | 3.0% | ||
SUPRIYA | ₹382.45 | 14.9% | 85.5% | ₹30.8b | ₹401.00 | PE25.6x | E21.6% | 0.2% | ||
RJF | €2.56 | 2.8% | 2.8% | €201.7m | €4.10 | PE21.4x | E46.1% | 1.6% | ||
1061 | HK$2.22 | -5.5% | -41.3% | HK$1.3b | HK$5.12 | PE4.6x | E28.7% | 4.1% |